Skip to content
StockMarketAgent
Communication Services / Electronic Gaming & MultimediaUpdated 2026-05-10 22:07 UTC

HEL/REMEDY stock hub

HEL/REMEDY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HEL/REMEDYis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
176.1M
Nasdaq Helsinki
Market data

Live price

Current market quote for this ticker.

Current price
HEL/REMEDY
In the news

Latest news · HEL/REMEDY

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E103.7
P25 15.6P50 16.5P75 19.8
Trailing P/En/a
P25 16.5P50 18.5P75 24.5
ROE-20.8
P25 -2.3P50 13.3P75 22.3
ROIC0.1
P25 1.6P50 7.9P75 12.6
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HEL/REMEDY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
201
Groups with data
11
Currency
EUR
Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Finland
Country code
FI
Employees
387
Employees Change
20%
Employees Change Percent
5.45
Enterprise value
EUR 165M
Exchange
Nasdaq Helsinki
Financial currency
EUR
First seen
2026-05-10
Industry
Electronic Gaming & Multimedia
Isin
FI4000251897
Last refreshed
2026-05-10
Market cap
EUR 176.1M
Price
EUR 12.96
Price currency
EUR
Rev Per Employee
153,772.61x
Sector
Communication Services
Sic
7372
Symbol
hel/REMEDY
Website
https://www.remedygames.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
-7.4%
EV Earnings
-12.66x
EV/EBITDA
38.52x
EV/FCF
248.5x
EV/Sales
2.77x
FCF yield
0.38%
Forward P/E
103.68x
P/B ratio
3.11x
P/S ratio
2.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
0.09%
EBITDA Margin
4.96%
FCF margin
1.12%
Gross margin
79.43%
Gross Profit
EUR 47.3M
Gross Profit Growth
38.61%
Gross Profit Growth Q
72.48%
Gross Profit Growth3 Y
14.08%
Gross Profit Growth5 Y
3.6%
Net Income
EUR -13M
Net Income Growth Quarters
3%
Net Income Growth Years
0%
Pretax Margin
-26.39%
Profit Margin
-21.9%
Profit Per Employee
EUR -33,669
ROA
0.04
Roa5y
-1.75
ROCE
0.08
ROE
-20.83
Roe5y
-8.56
ROIC
0.14
Roic5y
-5.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

19
MetricValue
Cagr1y
-26.46%
Cagr3y
-19.82%
Cagr5y
-21.46%
Div CAGR3
0%
Div CAGR5
-7.79%
EPS Growth Quarters
3
EPS Growth Years
0
FCF Growth
-87.85%
FCF Growth Q
-75.04%
FCF Growth3 Y
-57.36%
FCF Growth5 Y
-34.39%
OCF Growth
-58.98%
OCF Growth3 Y
-25.85%
OCF Growth5 Y
-17.5%
Revenue Growth
17.47x
Revenue Growth Q
46.26x
Revenue Growth Years
2x
Revenue Growth3 Y
10.94x
Revenue Growth5 Y
5.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
EUR 0.64
Assets
EUR 87.5M
Cash
EUR 29.4M
Current Assets
EUR 44.8M
Current Liabilities
EUR 13.8M
Debt
EUR 18.3M
Debt EBITDA
EUR 4.26
Debt Equity
EUR 0.32
Debt FCF
EUR 27.51
Equity
EUR 56.6M
Interest Coverage
0.04
Liabilities
EUR 31M
Long Term Assets
EUR 42.8M
Long Term Liabilities
EUR 17.2M
Net Cash
EUR 11.1M
Net Cash By Market Cap
EUR 6.32
Net Cash Growth
-55.98%
Net Debt EBITDA
EUR -3.77
Net Debt Equity
EUR -0.2
Net Debt FCF
EUR -16.76
Tangible Book Value
EUR 28.7M
Tangible Book Value Per Share
EUR 2.11
WACC
9.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
3.25
Net Working Capital
EUR 2.9M
Quick ratio
3.25
Working Capital
EUR 31M
Working Capital Turnover
EUR 1.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-0.64%
Dividend per share
EUR 0
Last Dividend
EUR 0.1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-26.45%
200-day SMA
14.08
3Y total return
-48.47%
50-day SMA
12.72
50-day SMA vs 200-day SMA
50under200
5Y total return
-70.1%
All Time High
49.9
All Time High Change
-74.03%
All Time High Date
2021-04-15
All Time Low
5.6
All Time Low Change
131.43%
All Time Low Date
2018-02-06
ATR
0.58
Beta
1.03
Beta1y
1.12
Beta2y
1.09
Ch YTD
-14.74
High
13.26
High52
19.04
High52 Date
2025-05-16
High52ch
-31.93%
Low
12.92
Low52
11.06
Low52 Date
2026-03-31
Low52ch
17.18%
Ma50ch
1.85%
Price vs 200-day SMA
-7.93%
RSI
54.01
RSI Monthly
41.5
RSI Weekly
45.04
Sharpe ratio
-0.64x
Sortino ratio
-0.77
Total Return
-0.64%
Tr YTD
-14.74
Tr1m
8%
Tr1w
4.85%
Tr3m
-10.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
EUR 56,000
Operating Income Growth5 Y
-66.49
Operating margin
0.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
9,132,331%
Net Borrowing
-1,439,000
Shares Insiders
32.8%
Shares Institutions
20.9%
Shares Out
13,590,451
Shares Qo Q
0.67%
Shares Yo Y
0.64%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

53
MetricValue
Adjusted FCF
EUR 664,000
Average Volume
6,944.5x
Bv Per Share
4.16
CAPEX
EUR -3.8M
Ch1m
8
Ch1w
4.85
Ch1y
-26.45
Ch3m
-10.5
Ch3y
-48.47
Ch5y
-70.38
Ch6m
0.31
Change
-2.56%
Change From Open
-2.26
Close
13.3
Days Gap
-0.3
Depreciation Amortization
2,894,000
Dollar Volume
62,337.6
Earnings Date
2026-05-05
EBIT
EUR 56,000
EBITDA
EUR 3M
EPS
EUR -0.96
F Score
6
FCF
EUR 664,000
FCF EV Yield
0.4x
FCF Per Share
EUR 0.05
Financing CF
-2,222,000
Fiscal Year End
December
Founded
1,995
Income Tax
EUR -2.7M
Investing CF
-13,646,000
Is Primary Listing
1
Last Earnings Date
2026-05-05
Last Report Date
2025-12-31
Ma150
13.85
Ma150ch
-6.41%
Ma20
12.66
Ma20ch
2.39%
Net CF
-11,355,000
Next Earnings Date
2026-08-11
Open
13.26
P FCF Ratio
265.3
P OCF Ratio
39.03
Position In Range
11.76
Ppne
5,760,000
Price Date
2026-05-08
Price EBITDA
EUR 59.71
Ptbv Ratio
6.15
Relative Volume
0.7x
Revenue
59,510,000x
Tax By Revenue
-4.49x
Tr6m
0.31%
Volume
4,810
Z Score
4.95
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HEL/REMEDY pay a dividend?

Capital-return profile for this ticker.

Performance

HEL/REMEDY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-26.4%
S&P 500 1Y: n/a
3Y total return
-48.5%
S&P 500 3Y: n/a
5Y total return
-70.1%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns HEL/REMEDY?

Insider, institutional, and short-interest positioning.

Institutional ownership
+20.9%
Share of float held by funds and institutions
Insider ownership
+32.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.6%
Negative means the company is buying back shares.
Technical

HEL/REMEDY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
54.0
Neutral momentum band
Price vs 200-day MA
-7.9%
50/200-day relationship not available
Beta (5Y)
1.03
Moves roughly with the market
Sharpe ratio
-0.64
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HEL/REMEDY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hel/REMEDY stock rating?

hel/REMEDY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hel/REMEDY analysis?

The full report lives at /stocks/hel/REMEDY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hel/REMEDY?

The latest report frames hel/REMEDY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hel/REMEDY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.